메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

Kelun-Biotech Presents Positive Results of Phase 3 Clinical S…

CHENGDU, China, Oct. 18, 2025 -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, results from a Phase 3 OptiTROP-Breast02 study of the Company's trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) (佳泰莱®) in previously treated locally advanced or metastatic hormone receptor-positive (HR+) and human epidermal growth factor receptor 2 -negative (HER2-) breast cancer (BC) was presented as a
- 김갑성 기자
- 2025-10-18 22:46
Manulife Hong Kong and JUST FEEL Promote Emotional Well-Be…

[ 메디채널 김갑성 기자 ] 500 family volunteers distribute over 10,000 free flags to encourage the public to share their feelings HONG KONG, Oct. 18, 2025 -- Manulife Hong Kong and JUST FEEL, a Hong Kong-based NGO dedicated to emotional education, successfully held the city's first-ever "My Flag Day" today. A total of 500 family volunteers from Manulife and nine of JUST FEEL's partner schools engaged with 10,000 citizens across the city, encouraging them to select a flag to wear, which would represent their current feelings. This initiative aims to raise public awareness of self-care
- 김갑성 기자
- 2025-10-18 16:23
Research Updates on a Phase III Clinical Trial of Anbenitama…

SUZHOU, China, Oct. 18, 2025 -- Alphamab Oncology (Stock Code: 9966.HK) announced that the first interim analysis results of a phase III clinical trial of anbenitamab injection (KN026), independently developed by the Company and co-developed with JMT-Bio Technology Co., Ltd., a wholly-owned subsidiary of CSPC Pharmaceutical Group Co., Ltd. (stock code: 1093.HK), in combination with chemotherapy as second-line or above treatment of HER2-positive gastric cancer (GC) (including gastroesophageal junction cancer (GEJ)) (Study ID: KN026-001, also known as KC-WISE), have been presented at the 2025 E
- 김갑성 기자
- 2025-10-18 14:59
SCG announces presentation of clinical results of SCG142 in…

SINGAPORE, Oct. 18, 2025 -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing next-generation immunotherapies for infectious diseases and their associated cancers, announced the presentation of first-in-human clinical data for SCG142 in an investigator-initiated Phase I trial (NCT06544720) in patients with recurrent or metastatic HPV-associated carcinomas. The poster will be presented at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany, on Saturday, 18 October 2025. This ongoing first-in-human trial evaluates the safety,
- 김갑성 기자
- 2025-10-18 13:00
One Heung Kong released the White Paper on Global Susta…

GUANGZHOU, China, Oct. 18, 2025 -- On October 14, the 2025 Global Engineering Conference and the first World Green Design Conference opened in Shanghai, China, drawing together over 250 former senior UN officials, academicians from different countries, and representatives from Fortune 500 companies. At the event, the White Paper on Global Sustainable and Healthy Living Environments (the Global Healthy Living Environment Report) was unveiled, setting a fresh yardstick for fostering healthy living across the globe. With the rapid pace of global urbanization, traditional residenti
- 김갑성 기자
- 2025-10-18 11:06
Avathon、航空宇宙事業向け自律プラットフォームを発表

[ 메디채널 김갑성 기자 ] 自律プラットフォームはコックピットから製造現場、格納庫、サプライチェーンへと拡大、航空宇宙事業を変革カリフォルニア州プレザントン（米国）, 2025年10月17日 -- Avathonは本日、航空宇宙事業向け[ 메디채널 김갑성 기자 ] 自律プラットフォーム「Autonomy for Aerospace Operations」の発売を発表しました。これは製造、サプライチェーン、保守データを統合するAIナレッジプラットフォームであり、航空宇宙ライフサイクル全体にわたる協調的な意思決定を推進するものです。同時に、このプラットフォームは生産品質、部品表（BOM）、サプライヤー調達、部品在庫状況、および労働供給力からの知見を統合することで、製造や物流における判断と運用中の整備や修理業務の同期を可能にすることから、即座に部品調達や修理が必要となる地上繋止機（AOG）事象の削減、処理能力と品質の向上、および機材運用準備態勢の強化につながるものでもあります。航空宇宙業界では、運用面での圧力がますます増大しています。航空会社や運航事業者は、老朽化しつつある機体を維持しながら複雑なネットワーク系統を修復する必要があります。一方、委託製造業者（OEM）は妥協が許されない品質基準を満足しながら生産
- 김갑성 기자
- 2025-10-17 22:50
Multitude Therapeutics Announces Promising Interim Phas…

[ 메디채널 김갑성 기자 ] AMT-116 is a potential first-in-class CD44v9-directed Topoisomerase I inhibitor-based ADC AMT-116 demonstrated a favorable safety profile, with manageable hematologic and Gastrointestinal toxicities Promising efficacies were observed in patients with heavily pretreated EGFR Wild-type NSCLC and other advanced solid tumors without CD44v9 pre-selection SHANGHAI, Oct. 17, 2025 -- Multitude Therapeutics, Inc., a clinical-stage company focused on the development of antibody-drug-conjugate (ADC) drugs, today announced initial data from its ongoing phase I/II
- 김갑성 기자
- 2025-10-17 22:00
Kelun-Biotech's Core product Trastuzumab Botidotin Appro…

CHENGDU, China, Oct. 17, 2025 -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's human epidermal growth factor receptor 2 (HER2)-directed antibody-drug conjugate (ADC) trastuzumab botidotin (also known as A166) was approved for marketing by the National Medical Products Administration (NMPA) for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer (BC) who have received one or more prior anti-HER2 therapy. The approval is based on a multi-center, randomized, open-label
- 김갑성 기자
- 2025-10-17 20:22
One Heung Kong released the White Paper on Global Susta…

GUANGZHOU, China, Oct. 17, 2025 -- On October 14, the 2025 Global Engineering Conference and the first World Green Design Conference opened in Shanghai, China, drawing together over 250 former senior UN officials, academicians from different countries, and representatives from Fortune 500 companies. At the event, the White Paper on Global Sustainable and Healthy Living Environments (the Global Healthy Living Environment Report) was unveiled, setting a fresh yardstick for fostering healthy living across the globe. With the rapid pace of global urbanization, traditional residenti
- 김갑성 기자
- 2025-10-17 18:39
One Heung Kong Leads the Way! New Global Benchmark for…

GUANGZHOU, China, Oct. 17, 2025 -- On October 14, the 2025 Global Engineering Conference and the first World Green Design Conference opened in Shanghai, China, drawing together over 250 former senior UN officials, academicians from different countries, and representatives from Fortune 500 companies. At the event, the White Paper on Global Sustainable and Healthy Living Environments (the Global Healthy Living Environment Report) was unveiled, setting a fresh yardstick for fostering healthy living across the globe. With the rapid pace of global urbanization, traditional residenti
- 김갑성 기자
- 2025-10-17 18:35

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2025-10-19_SUN

2025-10-18_SAT

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 10월 19일 02시 20분